Title: Observational Study on the Outcome of Supervised and Non-Supervised Therapy in Subject with Pulmonary Tuberculosis

Authors: Rajni Kant, Akhilesh Kumar, Rajiv Kumar, Deepmala Sinha, Sumit Kumar Mahato

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i6.103

Abstract

Background: The success of anti-tuberculosis programme is directly dependent on the adherence to the treatment, patient compliance, and correct combination of anti-tubercular drugs in the optimum doses for right duration. Lack of adherence to drug gives rise to resurgence and resistance which can be prevented if drug are given under direct supervision.

Aims and Objective: Supervised short-course therapy can have a good impact over patients on non supervised therapy who discontinue their treatment and become treatment failure case. In view of the above scenario the present study has been conducted at RIMS, a tertiary care hospital and adjoining PHC to study the likely impact of supervised over non supervised treatment.

Material and Methods: The present study was carried out in outdoor and indoor patients from the department of medicine, Rajendra institute of medical science, Ranchi and adjoining PHC during the period from October 2016 to April 2017

Result and Conclusion: Both supervised and non-supervised therapy are effective but the revised WHO regimen (DOTS regimen) directly observed short course therapy  increases the patient’s compliance and adherence to the treatment regimens and increased sputum smear conversion rate at the end of two months thereby concluding  that supervised therapy is superior  to  non supervised therapy when outcomes were compared.

Keywords: supervised and non supervised, antituberculosis drug, DOTS.

References

WHO 2008. WHO Global Report 2008: Global Tuberculosis control. WHO: Geneva Available at

http://www.unaids.org/sites/default/files/media_asset/who2008globaltbreport_en_0.Pdf.

2.      Harada N. (2006). Characteristics of a diagnostic method for tuberculosis infection based on    whole blood interferon-gamma assay. Kekkaku, 81(11): 681-6.

3.      WHO. Global Tuberculosis Control: WHO Report 2010. 2010.[September 18, 2011]. Available at: http://www​.who.int/tb​/publications/global_report​/2010/en/index.html.

4.      Government of India. TB India, 2006, RNTCP status report, DOTS for All-All for DOTS,  MOHFW, New Delhi, 2006.

5.      World Health Organization. Media Centre. Tuberculosis. Fact Sheet No. 104. Available at:   http://www.who.int/mediacentre/factsheets/fs104/en/index.html (last accessed on January 13, 2014).

6.      TB Facts.org. Information about Tuberculosis. TB Statistics for INDIA: TB Facts under   RNTCP. Available at: http://www.tbfacts.org/tb-statistics-india.html (last accessed on April  4, 2014)

7.      Chakraborthy AK, Epidemiology of tuberculosis current status in India. Indian J Med Res  [serial on line]. 2004 [cited on 2010 Nov 22]; 120: 248-76. Available from URL:  http://www.pub med.com.

8.      Anon WHO declares tuberculosis a global emergency. Soz Praventiv med. 1993; 38 (4):251–252.

9.      World Health Organization (WHO) Framework for effective tuberculosis control, WHO   document WHO/TB/94. 179, 1994Geneva, WHO. Available at :http://apps.who.int/iris/handle/10665/58717

10.  Murali Madhav S., Udaya Kiran N,Comparative study of dots and non-dots interventions in tuberculosis  cure.Indian Journal of Community-Medicine, XXIX(1), 2004,18-19.

11.  R Verma, P Khanna, Meena, S Prinja, A Comparative Study Between Dots & Non-Dots Patients In Two  Districts Of Haryana, India The Internet Journal of Epidemiology, 8(1),1-3.

12.  V. N. Balasubramanian, K. Oommen,R. Samuel, DOT or not? Direct observation of anti- tuberculosis treatment  and patient outcomes, Kerala State, India, INT J TUBERC LUNG DIS, 4(5), 40–413.

13.  Vasantha M, Gopi PG, Subramani R, Weight gain in patients with tuberculosis treated under  directly observed treatment short-course (DOTS), Indian J Tuberc, (2009), 56, 5-9.

14.  Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE, Eleven years of community based directly  observed therapy for tuberculosis. JAMA, 274, 1995, 945-951.

15.  Bawri S, Ali S, Phukan C, Tayal B, Baruwa P.A study of sputum conversion in new smear  positive pulmonary  tuberculosis cases at the monthly intervals of 1, 2 & 3 month under directly observed treatment, short course      (dots) regimen. Lung India, 25(3), 2008, 118-23.

16.  Rossana A, Ditangco, Melchor C, Clinical predictors of response to tuberculosis chemotherapy, Philippine Journal of Microbiology and Infectious Diseases,25, 1996,18-20.

17.  Leung AN, Muller NL, Pineda PR, FitzGerald JM. Primary tuberculosis in childhood: radiographic  manifestations. Radiology 1992; 182:87–91.

18.  S.L.Chadha, R-P.Bhagi, Treatment outcome in tuberculosis patients placed under directly    observed treatment short course (dots) a cohort study, Ind J. Tub, 47, 2000, 155.

19.  WHO Tuberculosis Fact Sheet. No.104. Geneva: WHO, 2000; 1-3.

20.  Govt. of India. Ministry of Health and Family Welfare, Central TB Division: TB India 2001:  RNTCP; New Delhi; Govt. of India, 1997; 1-5.

Corresponding Author

Akhilesh Kumar

Junior Resident, Department Of Pharmacology, RIMS, Ranchi-834009, Jharkhand

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile no.8987662969